Moderna is preparing to test Health Secretary Robert F. Kennedy Jr.'s tougher vaccine policies with a combination flu-COVID ...

An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

The new results helped boost Moderna’s stock by more than 4% in early trading Monday, though the company’s shares are still ...

Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to ...

In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...

Solid phase III efficacy results for Moderna Inc.’s seasonal influenza vaccine, mRNA-1010, may lead the company to resubmit a ...

Medical clinics in the western Bay of Plenty area are experiencing a spike in people presenting with influenza and Covid-19 infections. In June, Bethlehem Family Doctors contacted patients, saying it ...

Monitoring fungal spores in the outdoor air can predict surges in flu and COVID-19 infections, especially during the fall, ...